4

Changes in Ownership

Bicara Therapeutics Inc. Filed 2024-09-18 Acc 0001415889-24-023653

Director bought 1,833,000 shares at $18.00 ($32,994,000)

Director acquired 5,122,993 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Insider	Date	Transaction	Shares	Price	Value	Owned after	D/I
RA CAPITAL MANAGEMENT, L.P. Director	2024-09-16	Conversion	+2,622,898			2,622,898	I
RA CAPITAL MANAGEMENT, L.P. Director	2024-09-16	Conversion	+2,500,095			2,500,095	I
RA CAPITAL MANAGEMENT, L.P. Director	2024-09-16	Purchase	+1,680,520	$18.00	$30,249,360	4,303,418	I
RA CAPITAL MANAGEMENT, L.P. Director	2024-09-16	Purchase	+152,480	$18.00	$2,744,640	2,652,575	I
Derivatives
RA CAPITAL MANAGEMENT, L.P. Director	2024-09-16	Conversion · Series B Preferred Stock	−18,409,755			0	I
RA CAPITAL MANAGEMENT, L.P. Director	2024-09-16	Conversion · Series B Preferred Stock	−12,273,169			0	I
RA CAPITAL MANAGEMENT, L.P. Director	2024-09-16	Conversion · Series C Preferred Stock	−5,835,024			0	I
RA CAPITAL MANAGEMENT, L.P. Director	2024-09-16	Conversion · Series C Preferred Stock	−10,836,474			0	I
Open-market purchases · 1,833,000 sh · avg $18.00 · $32,994,000